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Abstract
Background: In the ovary, sarcomatoid carcinoma has been reported only as mural nodules in epithelial malignant
or borderline serous or mucinous cystic neoplasms, and in teratomas.
In this paper we report a rare case of a solid sarcomatoid carcinoma of the ovary, without accompanying
component of giant cells, pleomorphic cells, or glandular and other epithelial structures.
Case presentation: This case report refers to a sarcomatoid carcinoma of the ovary in in a 57 year-old
woman with abdominal pain.
Macroscopically, the neoplasm was a 15x10x5 cm ovarian mass that featured gray white solid fleshy areas,
interspersed with areas of necrosis, hemorrhage and cystic spaces filled with thick fluid. The epithelial
differentiation of the tumor was demonstrated by strong and diffuse reactivity to CAM5.2 and focal
immunoreactivity to EMA. A diagnosis of malignant mesenchymal tumor was excluded due to negativity for
desmin, smooth muscle actin, caldesmon, CD34, CD10, and myoglobin. Neural, neuroendocrine neoplasm,
melanoma and Perivascular Epithelioid Cell Tumor (PEComa) were excluded because of negativity for S100,
chromogranin, synaptophysin and HMB45.
Conclusion: Primary ovarian spindle cell carcinoma is a rare neoplasm, which must be considered in the
differential diagnosis of solid ovarian mass with spindle cell appearance. This case adds to our knowledge of
the biological behavior of these rare neoplasms. The distinction from true sarcomas and carcinosarcomas is
important because of the more favorable prognosis of the spindle cell carcinomas. However their diagnosis
necessitates a careful tissue sampling and immunohistochemical staining.
Keywords: Malignant mixed Müllerian tumors, Sarcomatoid carcinoma, Carcinosarcoma, Monophasic
sarcomatoid tumor, Biphasic tumor
Background
Sarcomatoid carcinoma is form of cancer, with controver-
sial histogenesis, which shares histological, cytological, or
molecular properties of both epithelial and mesenchymal
differentiation.
Sarcomatoid carcinoma is referred to a pure spindle
cell carcinoma which is distinguished from true sarcoma
by its positive staining to cytokeratins. Multiple sections
and immunohistochemical stains or ultrastructural study
are required to support the diagnosis [1, 2].
“The carcinosarcoma” is a neoplasm with carcinomat-
ous and sarcomatous elements [3, 4].
Sarcomatoid carcinomas, known also as spindle cell
(sarcomatoid) carcinomas, are rare malignancies and
have been reported in many organs such as the breast
[3, 5] urinary bladder [1, 2, 6], kidney [7] and lung [4, 8].
Ovarian anaplastic spindle cell carcinomas include three
different subtypes, rhabdoid, spindled (sarcomatoid) and
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pleomorphic in epithelial malignant [9, 10], or serous
and mucinous borderline [11, 12] cystic neoplasms, and
in teratomas [13].
In this paper, we report a rare case of a solid sarcoma-
toid carcinoma of the ovary of spindle cell type.
Case presentation
A 53-year-old woman presented to our institution com-
plaining of abdominal pain. Her personal history was
unremarkable. Physical examination revealed a palpable
mass lesion in the pelvic region. The results of labora-
tory investigations revealed increased CA125 levels
(176.56 U/ml) (normal value: < 35 U/ml). Pelvic magnetic
resonance imaging (MRI) scans suggested a malignant le-
sion located in the left ovary, showing the presence a large,
complex mass with cystic solid components and necrotic
areas. Hysterectomy with bilateral salpingo-oophorectomy,
pelvic lymph node dissection and omentectomy were
performed to establish stage of development of this
neoplasm.
Pathologic findings
On macroscopic examination, a left salpingo-oophorectomy
specimen revealed an intact 15x10x5 cm ovarian mass. A
cut section showed gray white solid fleshy areas, inter-
spersed with areas of necrosis, hemorrhage, and cystic
spaces filled with thick fluid (Fig. 1). Cystic spaces were
entirely submitted for histological evaluation.
For accurate microscopic examination of solid areas,
we used a sampling, suggested by other investigators
for diagnosis of mucinous borderline and malignant
tumors of the ovary [14]. In line with this protocol,
sampling of our tumor could be considered as optimal,
because was examined one section per 1 cm of the
maximum diameter [14].
Microscopic examination revealed that the cystic spaces,
which were entirely submitted for histological evaluation,
showed no epithelial lining (Fig. 2a) and that they
corresponded to edematous and hemorrhagic areas
due to the torsion of mass. In fact, the wall of these
spaces contained macrophages filled with hemosiderin
(Fig. 2b). The thick fluid observed macroscopically in
these spaces was not mucous material, but it corre-
sponded to fibrin, with pink network aspect (Fig. 2c).
The solid component of the neoplasm contained large
foci of coagulative tumor cell necrosis and predomin-
antly spindle cells, with moderate cytoplasm, arranged in
fascicles or a storiform pattern, mimicking mesenchymal
malignancy (Fig. 3a).
In other smaller areas, the spindle neoplastic elements
showed more abundant cytoplasm with epithelial-like
appearance. The nuclei were atypical and vesicular, with
evident nucleoli. Mitoses were frequent and sometimes
atypical (Fig. 3b).
In numerous sections examined, no benign or malig-
nant epithelial structures, nor histological elements, such
as giant cells or pleomorphic cells were observed.
Immunohistochemical analysis was performed to estab-
lish true nature of tumor differentiating epithelial from
mesenchymal, neuroendocrine neoplasms, melanoma and
uterine Perivascular Epithelioid Cell Tumor (PEComa),
sex cord tumors and (Gastrointestinal Stromal tumor)
GIST.
On immunohistochemistry, the tumor cells showed
strong and diffuse reactivity to Vimentin (Fig. 4a),
CAM5.2 (Fig. 4b) and focal positivity to cocktail of
keratins and EMA (Fig. 5). Immunoreactivity was
negative when staining for other antibodies such as
Ca 125, desmin, smooth muscle actin, S100, caldesmon,
CD34, calretinin, alpha-inhibin, CD10, myoglobin, S100
protein, HMB45, chromogranin, synaptophysin, and
c-kit.
Although a carcinomatous component was not recog-
nized at microscopic examination, the epithelial nature
Fig. 1 Left salpingo-oophorectomy specimen showing a 15x10x5 cm ovarian mass with gray white solid fleshy areas, interspersed with areas of
necrosis, hemorrhage, and cystic spaces
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of the tumor was established because of strong and dif-
fuse reactivity to CAM 5.2 and focal positivity to EMA
and cocktail of keratins.
Specimen of pelvic lymph node dissection did not
reveal presence of metastases.
Abdominal ultrasound, chest X-ray, total computed
tomography, or bone scan were unremarkable.
Therefore, the final diagnosis was primary ovarian
sarcomatoid carcinoma of pT1a N0 M0 stage of devel-
opment at the diagnosis.
The patient received six cycles of chemotherapy with
carboplatin-Taxol.
After one year from diagnosis, surgery and chemo-
therapy, the patient is free of disease.
Conclusions
Ovarian carcinosarcomas, also known as malignant mixed
mesodermal tumors or malignant mixed Müllerian tumors,
are exceedingly rare, and comprise only 1-3 % of ovarian
malignancies [14, 15].
Histologically, ovarian carcinosarcomas are consid-
ered biphasic tumors with both carcinomatous (epithe-
lial) and sarcomatous (stromal) elements. They can be
sub-classified as “heterologous” or “homologous” based
on the presence or absence of a stromal component
containing mesenchymal tissues not normally found at
the primary tumour site.
Spindle cell carcinoma is defined as a spindle cell
neoplasm, that simulates a sarcoma and demonstrates
epithelial differentiation in both immunohistochemis-
try and electron microscopy [1, 2, 4–8].
Anaplastic carcinoma of spindle cell type is an ex-
ceedingly rare ovarian neoplasm, with controversial
histogenesis, with less than ten cases reported in the
English medical literature. Three different types have
been described, rhabdoid, spindled (sarcomatoid) and
pleomorphic [10].
To the best of our knowledge, in the ovary, sarcoma-
toid carcinoma has only been reported as mural nodules
in epithelial malignant [9, 10], or borderline [11, 12]
cystic neoplasms, and in teratomas [13].
In our case, sarcomatoid carcinoma of the ovary was
characterized only by a spindle cell component without
epithelial structures.
In this case, the epithelial differentiation of the tumor
was demonstrated by strong and diffuse reactivity to
CAM 5.2 and focal positivity to EMA. A diagnosis of
malignant mesenchymal tumor was excluded due to
negativity for desmin, smooth muscle actin, caldesmon,
CD34, CD10, and myoglobin. Neural, neuroendocrine
neoplasm and melanoma and uterine Perivascular Epi-
thelioid Cell Tumor (PEComa) were excluded because
of negativity for S100, chromogranin, synaptophysin
and HMB45.
Other neoplams such as sex cord tumors and (Gastro-
intestinal Stromal tumor) GIST were excluded due to
negativity to negativity for alpha-Inhibin, and C-kit.
In many organs such as the kidney [16, 17], breast [3],
and urinary bladder [1] sarcomatoid carcinomas are neo-
plasms, with poor prognosis. As a consequence of the
Fig. 2 R1: Microscopic examination revealed that the cystic spaces
showed no epithelial lining (a: Hematoxylin-eosin x 100). Note the
presence of macrophages filled with hemosiderin in the wall of these
spaces (b: Hematoxylin-eosin, Arrow x 200) and fibrin with pink
network aspect in the cavity of cystic space (c: Hematoxylin-eosin, x 200)
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relative rarity and diagnostic heterogeneity of these tu-
mors, it has proven difficult to properly predict their
behaviour and to determine optimal management.
Although it was first thought to carry an invariably
unfavorable prognosis, recent data indicate that this does
not apply to Ia tumors [10].
Our findings are consistent with the above mentioned
data. In this case, at diagnosis, the neoplasm was located
within the ovary (Stage: pT1a), without invasion of sur-
rounding tissue and lymph nodes metastases and was
treated with combined chemotherapy treatment with
carboplatin and taxol. After one year from diagnosis, the
Fig. 3 The solid component of the neoplasm contained large foci of coagulative tumor cell necrosis and spindle cells, with moderate cytoplasm,
arranged predominantly in fascicles or a storiform pattern, mimicking mesenchymal malignancy (a: Hematoxylin-eosin x 100). In other smaller
areas, the neoplastic elements showed abundant eosinophilic cytoplasm. The nuclei were atypical and vesicular, with evident nucleoli. Mitoses
were frequent and sometimes atypical (b: Hematoxylin-eosin x 400)
Fig. 4 On immunohistochemistry, the tumor cells showed diffuse strong positive immunoreactivity for Vimentin (a: Vimentin x 200) and strong
positive reaction for CAM 5.2 (b: CAM 5.2 x 400)
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patient is free of disease and this might suggest that
its aggressiveness is lower than anaplastic spindle cell
carcinoma, present in other organs.
The sarcomas are characterized by presence of malig-
nant mesenchymal elements and these include stromal
cell sarcomas, fibrosarcomas, leiomyosarcomas, neuro-
fibrosarcomas, rhabdomyosarcomas, chondrosarcomas,
angiosarcomas, and liposarcomas [18]. Carcinosarcoma
is a mixed Müllerian (MMT), and is characterized by
the presence of both carcinomatous and sarcomatous
component. Ovarian MMTs can be classified as hom-
ologous or heterologous. In the homologous subtype
can be observed tissue normally present in the ovary.
On the contrary, in the heterologous subtype the neo-
plasm shows tissues that is not normally present in the
ovary [19].
Extensive sampling is mandatory for the exclusion of
MMTs, which carry a more ominous prognosis [19].
Our case refers to a spindle cell carcinoma of the
ovary which appears as a solid mass. For diagnosis
in this case cystic spaces were entirely submitted for
histological evaluation and solid areas were examined
using protocol used by other Author for diagnosis of
mucinous borderline and malignant tumors of the
ovary [14].
Furthermore, in our opinion, this case, is in line with
other cases of sarcomatoid carcinomas observed in dif-
ferent organs.
This is the first case report of sarcomatoid (spindle
cell carcinoma) of the ovary, which appears as a solid
mass. Moreover, this case demonstrates that findings of
malignant spindle cell proliferation does not imply that
this entity is a sarcoma or malignant Mixed Müllerian
Tumor (MMT). Additionally, careful tissue sampling
and immunohistochemical analysis to distinguish be-
tween these different entities is mandatory.
Fig. 5 On immunohistochemistry, the tumor cells showed focal positivity to EMA (x 100)
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